nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—SLC15A2—melanoma	0.72	1	CbGaD
Cefdinir—SLC22A5—Dactinomycin—melanoma	0.148	1	CbGbCtD
Cefdinir—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.00709	0.218	CbGpPWpGaD
Cefdinir—Erythema nodosum—Vemurafenib—melanoma	0.00377	0.0407	CcSEcCtD
Cefdinir—Diarrhoea haemorrhagic—Docetaxel—melanoma	0.00219	0.0237	CcSEcCtD
Cefdinir—Enterocolitis—Docetaxel—melanoma	0.002	0.0215	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—IL24—melanoma	0.00192	0.0589	CbGpPWpGaD
Cefdinir—Interstitial pneumonia—Temozolomide—melanoma	0.00173	0.0186	CcSEcCtD
Cefdinir—Nephropathy toxic—Bleomycin—melanoma	0.00172	0.0186	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—CXCL1—melanoma	0.00163	0.0501	CbGpPWpGaD
Cefdinir—Disseminated intravascular coagulation—Docetaxel—melanoma	0.00155	0.0167	CcSEcCtD
Cefdinir—Nephropathy toxic—Carmustine—melanoma	0.0015	0.0162	CcSEcCtD
Cefdinir—Rash maculo-papular—Vemurafenib—melanoma	0.00148	0.016	CcSEcCtD
Cefdinir—Interstitial lung disease—Bleomycin—melanoma	0.0014	0.0151	CcSEcCtD
Cefdinir—Digestion impaired—Temozolomide—melanoma	0.00125	0.0135	CcSEcCtD
Cefdinir—Interstitial lung disease—Carmustine—melanoma	0.00122	0.0131	CcSEcCtD
Cefdinir—Coagulopathy—Dactinomycin—melanoma	0.00118	0.0128	CcSEcCtD
Cefdinir—Interstitial lung disease—Temozolomide—melanoma	0.00118	0.0127	CcSEcCtD
Cefdinir—Interstitial pneumonia—Docetaxel—melanoma	0.00115	0.0124	CcSEcCtD
Cefdinir—Cholestasis—Temozolomide—melanoma	0.0011	0.0118	CcSEcCtD
Cefdinir—Coagulopathy—Temozolomide—melanoma	0.00107	0.0115	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00107	0.0115	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—CUBN—melanoma	0.000991	0.0304	CbGpPWpGaD
Cefdinir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000991	0.0304	CbGpPWpGaD
Cefdinir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.000955	0.0293	CbGpPWpGaD
Cefdinir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000919	0.0282	CbGpPWpGaD
Cefdinir—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.000905	0.00976	CcSEcCtD
Cefdinir—Ceftibuten—SLC15A2—melanoma	0.000878	0.132	CrCbGaD
Cefdinir—Aplastic anaemia—Dactinomycin—melanoma	0.000865	0.00933	CcSEcCtD
Cefdinir—Vaginal inflammation—Temozolomide—melanoma	0.000834	0.00899	CcSEcCtD
Cefdinir—Candida infection—Carmustine—melanoma	0.000824	0.00888	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—PRDX2—melanoma	0.000816	0.025	CbGpPWpGaD
Cefdinir—Candida infection—Temozolomide—melanoma	0.000796	0.00858	CcSEcCtD
Cefdinir—Vaginal infection—Temozolomide—melanoma	0.000787	0.00849	CcSEcCtD
Cefdinir—Ileus—Docetaxel—melanoma	0.000783	0.00845	CcSEcCtD
Cefdinir—Interstitial lung disease—Docetaxel—melanoma	0.000783	0.00845	CcSEcCtD
Cefdinir—Aplastic anaemia—Temozolomide—melanoma	0.000783	0.00844	CcSEcCtD
Cefdinir—Erythema multiforme—Vemurafenib—melanoma	0.000775	0.00835	CcSEcCtD
Cefdinir—Hepatic failure—Dactinomycin—melanoma	0.000745	0.00803	CcSEcCtD
Cefdinir—Cefepime—SLC15A2—melanoma	0.000723	0.109	CrCbGaD
Cefdinir—Hepatic failure—Temozolomide—melanoma	0.000673	0.00726	CcSEcCtD
Cefdinir—Cefuroxime—SLC15A2—melanoma	0.000654	0.0985	CrCbGaD
Cefdinir—Dermatitis exfoliative—Temozolomide—melanoma	0.000641	0.00692	CcSEcCtD
Cefdinir—Purpura—Temozolomide—melanoma	0.000628	0.00677	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—SKI—melanoma	0.000622	0.0191	CbGpPWpGaD
Cefdinir—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000603	0.0065	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000603	0.0065	CcSEcCtD
Cefdinir—Pancytopenia—Bleomycin—melanoma	0.000589	0.00635	CcSEcCtD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000583	0.0179	CbGpPWpGaD
Cefdinir—Anaphylactic shock—Vemurafenib—melanoma	0.000582	0.00628	CcSEcCtD
Cefdinir—Cefixime—SLC15A2—melanoma	0.000566	0.0851	CrCbGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.000562	0.0173	CbGpPWpGaD
Cefdinir—Pneumonia—Bleomycin—melanoma	0.000556	0.006	CcSEcCtD
Cefdinir—Pancytopenia—Dactinomycin—melanoma	0.000549	0.00592	CcSEcCtD
Cefdinir—Acute coronary syndrome—Bleomycin—melanoma	0.000545	0.00588	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000545	0.00588	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000545	0.00588	CcSEcCtD
Cefdinir—Myocardial infarction—Bleomycin—melanoma	0.000542	0.00585	CcSEcCtD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000541	0.0166	CbGpPWpGaD
Cefdinir—Neutropenia—Dactinomycin—melanoma	0.000541	0.00583	CcSEcCtD
Cefdinir—Stomatitis—Bleomycin—melanoma	0.000539	0.00581	CcSEcCtD
Cefdinir—Ceftazidime—SLC15A2—melanoma	0.000532	0.08	CrCbGaD
Cefdinir—Candida infection—Docetaxel—melanoma	0.000529	0.00571	CcSEcCtD
Cefdinir—Haematuria—Bleomycin—melanoma	0.000527	0.00569	CcSEcCtD
Cefdinir—Pneumonia—Dactinomycin—melanoma	0.000519	0.00559	CcSEcCtD
Cefdinir—Cefaclor—SLC15A2—melanoma	0.000517	0.0779	CrCbGaD
Cefdinir—Pancytopenia—Carmustine—melanoma	0.000514	0.00554	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000511	0.00551	CcSEcCtD
Cefdinir—Neutropenia—Carmustine—melanoma	0.000506	0.00546	CcSEcCtD
Cefdinir—Decreased appetite—Vemurafenib—melanoma	0.000506	0.00546	CcSEcCtD
Cefdinir—Stomatitis—Dactinomycin—melanoma	0.000503	0.00542	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Vemurafenib—melanoma	0.000502	0.00542	CcSEcCtD
Cefdinir—Haemoglobin—Bleomycin—melanoma	0.000499	0.00538	CcSEcCtD
Cefdinir—Constipation—Vemurafenib—melanoma	0.000498	0.00537	CcSEcCtD
Cefdinir—Pancytopenia—Temozolomide—melanoma	0.000497	0.00536	CcSEcCtD
Cefdinir—Haemorrhage—Bleomycin—melanoma	0.000496	0.00535	CcSEcCtD
Cefdinir—Cefradine—SLC15A2—melanoma	0.000496	0.0747	CrCbGaD
Cefdinir—Neutropenia—Temozolomide—melanoma	0.000489	0.00528	CcSEcCtD
Cefdinir—Pneumonia—Carmustine—melanoma	0.000485	0.00524	CcSEcCtD
Cefdinir—Agranulocytosis—Dactinomycin—melanoma	0.000481	0.00519	CcSEcCtD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000475	0.0146	CbGpPWpGaD
Cefdinir—Renal failure—Carmustine—melanoma	0.000474	0.00512	CcSEcCtD
Cefdinir—Stomatitis—Carmustine—melanoma	0.00047	0.00507	CcSEcCtD
Cefdinir—Pneumonia—Temozolomide—melanoma	0.000469	0.00506	CcSEcCtD
Cefdinir—Cefadroxil—SLC15A2—melanoma	0.000469	0.0706	CrCbGaD
Cefdinir—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000462	0.00499	CcSEcCtD
Cefdinir—Body temperature increased—Vemurafenib—melanoma	0.00046	0.00496	CcSEcCtD
Cefdinir—Stomatitis—Temozolomide—melanoma	0.000455	0.0049	CcSEcCtD
Cefdinir—Hepatic failure—Docetaxel—melanoma	0.000448	0.00483	CcSEcCtD
Cefdinir—Erythema multiforme—Dactinomycin—melanoma	0.000438	0.00472	CcSEcCtD
Cefdinir—Haemoglobin—Carmustine—melanoma	0.000435	0.0047	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—ETS1—melanoma	0.000434	0.0133	CbGpPWpGaD
Cefdinir—Haemorrhage—Carmustine—melanoma	0.000433	0.00467	CcSEcCtD
Cefdinir—Hypersensitivity—Vemurafenib—melanoma	0.000429	0.00462	CcSEcCtD
Cefdinir—Renal impairment—Docetaxel—melanoma	0.000423	0.00456	CcSEcCtD
Cefdinir—Haemoglobin—Temozolomide—melanoma	0.000421	0.00454	CcSEcCtD
Cefdinir—Haemorrhage—Temozolomide—melanoma	0.000419	0.00452	CcSEcCtD
Cefdinir—Asthenia—Vemurafenib—melanoma	0.000418	0.0045	CcSEcCtD
Cefdinir—Cardiac failure—Docetaxel—melanoma	0.000412	0.00445	CcSEcCtD
Cefdinir—Pruritus—Vemurafenib—melanoma	0.000412	0.00444	CcSEcCtD
Cefdinir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000411	0.0126	CbGpPWpGaD
Cefdinir—Cefotaxime—SLC15A2—melanoma	0.000409	0.0616	CrCbGaD
Cefdinir—Ceftriaxone—SLC15A2—melanoma	0.000403	0.0607	CrCbGaD
Cefdinir—MPO—IL23-mediated signaling events—NOS2—melanoma	0.000398	0.0122	CbGpPWpGaD
Cefdinir—Diarrhoea—Vemurafenib—melanoma	0.000398	0.00429	CcSEcCtD
Cefdinir—Erythema multiforme—Temozolomide—melanoma	0.000396	0.00427	CcSEcCtD
Cefdinir—Leukopenia—Bleomycin—melanoma	0.000387	0.00417	CcSEcCtD
Cefdinir—Dizziness—Vemurafenib—melanoma	0.000385	0.00415	CcSEcCtD
Cefdinir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000382	0.0117	CbGpPWpGaD
Cefdinir—Vomiting—Vemurafenib—melanoma	0.00037	0.00399	CcSEcCtD
Cefdinir—Chest pain—Bleomycin—melanoma	0.000368	0.00397	CcSEcCtD
Cefdinir—Rash—Vemurafenib—melanoma	0.000367	0.00396	CcSEcCtD
Cefdinir—Dermatitis—Vemurafenib—melanoma	0.000367	0.00395	CcSEcCtD
Cefdinir—Headache—Vemurafenib—melanoma	0.000365	0.00393	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000362	0.00391	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000362	0.00391	CcSEcCtD
Cefdinir—Leukopenia—Dactinomycin—melanoma	0.000361	0.00389	CcSEcCtD
Cefdinir—Cefalotin—SLC15A2—melanoma	0.000353	0.0531	CrCbGaD
Cefdinir—Anaphylactic shock—Bleomycin—melanoma	0.000353	0.0038	CcSEcCtD
Cefdinir—Agitation—Carmustine—melanoma	0.000347	0.00374	CcSEcCtD
Cefdinir—Nausea—Vemurafenib—melanoma	0.000346	0.00373	CcSEcCtD
Cefdinir—Thrombocytopenia—Bleomycin—melanoma	0.000345	0.00372	CcSEcCtD
Cefdinir—Leukopenia—Carmustine—melanoma	0.000338	0.00364	CcSEcCtD
Cefdinir—Anorexia—Bleomycin—melanoma	0.000336	0.00363	CcSEcCtD
Cefdinir—Agitation—Temozolomide—melanoma	0.000335	0.00361	CcSEcCtD
Cefdinir—Pancytopenia—Docetaxel—melanoma	0.00033	0.00356	CcSEcCtD
Cefdinir—Convulsion—Carmustine—melanoma	0.000327	0.00352	CcSEcCtD
Cefdinir—Leukopenia—Temozolomide—melanoma	0.000326	0.00352	CcSEcCtD
Cefdinir—Hypertension—Carmustine—melanoma	0.000326	0.00351	CcSEcCtD
Cefdinir—Neutropenia—Docetaxel—melanoma	0.000325	0.00351	CcSEcCtD
Cefdinir—Thrombocytopenia—Dactinomycin—melanoma	0.000322	0.00347	CcSEcCtD
Cefdinir—Chest pain—Carmustine—melanoma	0.000321	0.00346	CcSEcCtD
Cefdinir—Cephalexin—SLC15A2—melanoma	0.000321	0.0483	CrCbGaD
Cefdinir—MPO—Folate Metabolism—IL4—melanoma	0.000318	0.00976	CbGpPWpGaD
Cefdinir—Convulsion—Temozolomide—melanoma	0.000316	0.00341	CcSEcCtD
Cefdinir—Hypertension—Temozolomide—melanoma	0.000315	0.00339	CcSEcCtD
Cefdinir—Anorexia—Dactinomycin—melanoma	0.000313	0.00338	CcSEcCtD
Cefdinir—Pneumonia—Docetaxel—melanoma	0.000312	0.00336	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—ICAM1—melanoma	0.000311	0.00953	CbGpPWpGaD
Cefdinir—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000307	0.00332	CcSEcCtD
Cefdinir—Decreased appetite—Bleomycin—melanoma	0.000307	0.00331	CcSEcCtD
Cefdinir—Acute coronary syndrome—Docetaxel—melanoma	0.000306	0.0033	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—IFNG—melanoma	0.000305	0.00938	CbGpPWpGaD
Cefdinir—Renal failure—Docetaxel—melanoma	0.000305	0.00329	CcSEcCtD
Cefdinir—Myocardial infarction—Docetaxel—melanoma	0.000304	0.00328	CcSEcCtD
Cefdinir—Dry mouth—Temozolomide—melanoma	0.000303	0.00327	CcSEcCtD
Cefdinir—Stomatitis—Docetaxel—melanoma	0.000302	0.00326	CcSEcCtD
Cefdinir—Jaundice—Docetaxel—melanoma	0.000302	0.00326	CcSEcCtD
Cefdinir—Conjunctivitis—Docetaxel—melanoma	0.000301	0.00325	CcSEcCtD
Cefdinir—Thrombocytopenia—Carmustine—melanoma	0.000301	0.00325	CcSEcCtD
Cefdinir—Anaphylactic shock—Temozolomide—melanoma	0.000297	0.00321	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—CD4—melanoma	0.000295	0.00905	CbGpPWpGaD
Cefdinir—Anorexia—Carmustine—melanoma	0.000293	0.00316	CcSEcCtD
Cefdinir—Thrombocytopenia—Temozolomide—melanoma	0.000291	0.00314	CcSEcCtD
Cefdinir—Agranulocytosis—Docetaxel—melanoma	0.000289	0.00312	CcSEcCtD
Cefdinir—Decreased appetite—Dactinomycin—melanoma	0.000286	0.00308	CcSEcCtD
Cefdinir—Anorexia—Temozolomide—melanoma	0.000284	0.00306	CcSEcCtD
Cefdinir—Haemoglobin—Docetaxel—melanoma	0.00028	0.00302	CcSEcCtD
Cefdinir—Body temperature increased—Bleomycin—melanoma	0.000279	0.00301	CcSEcCtD
Cefdinir—Haemorrhage—Docetaxel—melanoma	0.000278	0.003	CcSEcCtD
Cefdinir—Insomnia—Carmustine—melanoma	0.000278	0.003	CcSEcCtD
Cefdinir—Somnolence—Carmustine—melanoma	0.000274	0.00295	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—IL2—melanoma	0.000271	0.00833	CbGpPWpGaD
Cefdinir—Insomnia—Temozolomide—melanoma	0.000269	0.0029	CcSEcCtD
Cefdinir—Gastrointestinal pain—Dactinomycin—melanoma	0.000269	0.0029	CcSEcCtD
Cefdinir—Decreased appetite—Carmustine—melanoma	0.000268	0.00289	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Carmustine—melanoma	0.000266	0.00287	CcSEcCtD
Cefdinir—Somnolence—Temozolomide—melanoma	0.000264	0.00285	CcSEcCtD
Cefdinir—Erythema multiforme—Docetaxel—melanoma	0.000263	0.00284	CcSEcCtD
Cefdinir—Constipation—Carmustine—melanoma	0.000263	0.00284	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	0.000262	0.00804	CbGpPWpGaD
Cefdinir—Dyspepsia—Temozolomide—melanoma	0.000262	0.00282	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000261	0.008	CbGpPWpGaD
Cefdinir—Abdominal pain—Dactinomycin—melanoma	0.00026	0.0028	CcSEcCtD
Cefdinir—Body temperature increased—Dactinomycin—melanoma	0.00026	0.0028	CcSEcCtD
Cefdinir—Hypersensitivity—Bleomycin—melanoma	0.00026	0.0028	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—ALB—melanoma	0.000259	0.00795	CbGpPWpGaD
Cefdinir—Decreased appetite—Temozolomide—melanoma	0.000259	0.00279	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Temozolomide—melanoma	0.000257	0.00277	CcSEcCtD
Cefdinir—Constipation—Temozolomide—melanoma	0.000254	0.00274	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—NFKB1—melanoma	0.000254	0.0078	CbGpPWpGaD
Cefdinir—Asthenia—Bleomycin—melanoma	0.000253	0.00273	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—ICAM1—melanoma	0.000253	0.00775	CbGpPWpGaD
Cefdinir—Gastrointestinal pain—Carmustine—melanoma	0.000252	0.00271	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000251	0.00771	CbGpPWpGaD
Cefdinir—Pruritus—Bleomycin—melanoma	0.000249	0.00269	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000247	0.00759	CbGpPWpGaD
Cefdinir—Body temperature increased—Carmustine—melanoma	0.000243	0.00262	CcSEcCtD
Cefdinir—Abdominal pain—Carmustine—melanoma	0.000243	0.00262	CcSEcCtD
Cefdinir—Gastrointestinal pain—Temozolomide—melanoma	0.000243	0.00262	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	0.000243	0.00746	CbGpPWpGaD
Cefdinir—Hypersensitivity—Dactinomycin—melanoma	0.000242	0.00261	CcSEcCtD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000242	0.00744	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000242	0.00743	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCB5—melanoma	0.000239	0.00734	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000238	0.0073	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000237	0.00727	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IFNG—melanoma	0.000236	0.00725	CbGpPWpGaD
Cefdinir—Asthenia—Dactinomycin—melanoma	0.000236	0.00254	CcSEcCtD
Cefdinir—Body temperature increased—Temozolomide—melanoma	0.000235	0.00254	CcSEcCtD
Cefdinir—Abdominal pain—Temozolomide—melanoma	0.000235	0.00254	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—STAT3—melanoma	0.000228	0.00701	CbGpPWpGaD
Cefdinir—Hypersensitivity—Carmustine—melanoma	0.000227	0.00245	CcSEcCtD
Cefdinir—Diarrhoea—Dactinomycin—melanoma	0.000225	0.00243	CcSEcCtD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000225	0.0069	CbGpPWpGaD
Cefdinir—Vomiting—Bleomycin—melanoma	0.000224	0.00242	CcSEcCtD
Cefdinir—Rash—Bleomycin—melanoma	0.000222	0.0024	CcSEcCtD
Cefdinir—Dermatitis—Bleomycin—melanoma	0.000222	0.0024	CcSEcCtD
Cefdinir—Asthenia—Carmustine—melanoma	0.000221	0.00238	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.00022	0.00674	CbGpPWpGaD
Cefdinir—Hypersensitivity—Temozolomide—melanoma	0.000219	0.00236	CcSEcCtD
Cefdinir—Leukopenia—Docetaxel—melanoma	0.000217	0.00234	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000216	0.00663	CbGpPWpGaD
Cefdinir—Asthenia—Temozolomide—melanoma	0.000213	0.0023	CcSEcCtD
Cefdinir—Loss of consciousness—Docetaxel—melanoma	0.000213	0.0023	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—ALB—melanoma	0.000211	0.00647	CbGpPWpGaD
Cefdinir—Diarrhoea—Carmustine—melanoma	0.000211	0.00227	CcSEcCtD
Cefdinir—Pruritus—Temozolomide—melanoma	0.00021	0.00227	CcSEcCtD
Cefdinir—Convulsion—Docetaxel—melanoma	0.00021	0.00226	CcSEcCtD
Cefdinir—Nausea—Bleomycin—melanoma	0.000209	0.00226	CcSEcCtD
Cefdinir—Hypertension—Docetaxel—melanoma	0.000209	0.00226	CcSEcCtD
Cefdinir—Vomiting—Dactinomycin—melanoma	0.000209	0.00226	CcSEcCtD
Cefdinir—Rash—Dactinomycin—melanoma	0.000207	0.00224	CcSEcCtD
Cefdinir—Chest pain—Docetaxel—melanoma	0.000206	0.00223	CcSEcCtD
Cefdinir—Dizziness—Carmustine—melanoma	0.000204	0.0022	CcSEcCtD
Cefdinir—Diarrhoea—Temozolomide—melanoma	0.000204	0.0022	CcSEcCtD
Cefdinir—Dry mouth—Docetaxel—melanoma	0.000202	0.00218	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—ICAM1—melanoma	0.000201	0.00616	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—KIT—melanoma	0.0002	0.00614	CbGpPWpGaD
Cefdinir—Anaphylactic shock—Docetaxel—melanoma	0.000198	0.00213	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—TNF—melanoma	0.000198	0.00607	CbGpPWpGaD
Cefdinir—Dizziness—Temozolomide—melanoma	0.000197	0.00212	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—NFKB1—melanoma	0.000197	0.00603	CbGpPWpGaD
Cefdinir—Vomiting—Carmustine—melanoma	0.000196	0.00211	CcSEcCtD
Cefdinir—Nausea—Dactinomycin—melanoma	0.000195	0.00211	CcSEcCtD
Cefdinir—Shock—Docetaxel—melanoma	0.000195	0.0021	CcSEcCtD
Cefdinir—Rash—Carmustine—melanoma	0.000194	0.00209	CcSEcCtD
Cefdinir—Dermatitis—Carmustine—melanoma	0.000194	0.00209	CcSEcCtD
Cefdinir—Thrombocytopenia—Docetaxel—melanoma	0.000194	0.00209	CcSEcCtD
Cefdinir—Headache—Carmustine—melanoma	0.000193	0.00208	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—IFNG—melanoma	0.000192	0.0059	CbGpPWpGaD
Cefdinir—Vomiting—Temozolomide—melanoma	0.000189	0.00204	CcSEcCtD
Cefdinir—Anorexia—Docetaxel—melanoma	0.000189	0.00203	CcSEcCtD
Cefdinir—Rash—Temozolomide—melanoma	0.000188	0.00202	CcSEcCtD
Cefdinir—Dermatitis—Temozolomide—melanoma	0.000187	0.00202	CcSEcCtD
Cefdinir—Headache—Temozolomide—melanoma	0.000186	0.00201	CcSEcCtD
Cefdinir—Nausea—Carmustine—melanoma	0.000183	0.00197	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	0.000182	0.00557	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—PIK3CA—melanoma	0.00018	0.00553	CbGpPWpGaD
Cefdinir—Insomnia—Docetaxel—melanoma	0.000179	0.00193	CcSEcCtD
Cefdinir—Nausea—Temozolomide—melanoma	0.000177	0.00191	CcSEcCtD
Cefdinir—Somnolence—Docetaxel—melanoma	0.000176	0.0019	CcSEcCtD
Cefdinir—Dyspepsia—Docetaxel—melanoma	0.000174	0.00188	CcSEcCtD
Cefdinir—Decreased appetite—Docetaxel—melanoma	0.000172	0.00185	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—IL2—melanoma	0.000171	0.00524	CbGpPWpGaD
Cefdinir—Gastrointestinal disorder—Docetaxel—melanoma	0.000171	0.00184	CcSEcCtD
Cefdinir—Constipation—Docetaxel—melanoma	0.000169	0.00182	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	0.000169	0.00517	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—ALB—melanoma	0.000167	0.00514	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ARL2—melanoma	0.000166	0.00509	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CDKN2A—melanoma	0.000163	0.00499	CbGpPWpGaD
Cefdinir—Gastrointestinal pain—Docetaxel—melanoma	0.000162	0.00174	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—BCL2—melanoma	0.00016	0.00491	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—NFKB1—melanoma	0.00016	0.00491	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL6—melanoma	0.00016	0.0049	CbGpPWpGaD
Cefdinir—Abdominal pain—Docetaxel—melanoma	0.000156	0.00169	CcSEcCtD
Cefdinir—Body temperature increased—Docetaxel—melanoma	0.000156	0.00169	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—CD4—melanoma	0.000153	0.0047	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—TNF—melanoma	0.000153	0.00469	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IFNG—melanoma	0.000153	0.00469	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—PTGS2—melanoma	0.000152	0.00466	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—PTGS2—melanoma	0.000146	0.00449	CbGpPWpGaD
Cefdinir—Hypersensitivity—Docetaxel—melanoma	0.000146	0.00157	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—CDKN1B—melanoma	0.000144	0.00442	CbGpPWpGaD
Cefdinir—Asthenia—Docetaxel—melanoma	0.000142	0.00153	CcSEcCtD
Cefdinir—Pruritus—Docetaxel—melanoma	0.00014	0.00151	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—CCND1—melanoma	0.000137	0.00421	CbGpPWpGaD
Cefdinir—Diarrhoea—Docetaxel—melanoma	0.000135	0.00146	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—CDKN1A—melanoma	0.000133	0.00408	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000132	0.00407	CbGpPWpGaD
Cefdinir—Dizziness—Docetaxel—melanoma	0.000131	0.00141	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000128	0.00392	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—NFKB1—melanoma	0.000127	0.0039	CbGpPWpGaD
Cefdinir—Vomiting—Docetaxel—melanoma	0.000126	0.00136	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000126	0.00386	CbGpPWpGaD
Cefdinir—Rash—Docetaxel—melanoma	0.000125	0.00135	CcSEcCtD
Cefdinir—Dermatitis—Docetaxel—melanoma	0.000125	0.00134	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—TNF—melanoma	0.000124	0.00382	CbGpPWpGaD
Cefdinir—Headache—Docetaxel—melanoma	0.000124	0.00134	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—IL6—melanoma	0.000123	0.00379	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000123	0.00377	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000121	0.00371	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00012	0.00369	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—NRAS—melanoma	0.000118	0.00363	CbGpPWpGaD
Cefdinir—Nausea—Docetaxel—melanoma	0.000117	0.00127	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000112	0.00343	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—MYC—melanoma	0.00011	0.00338	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00011	0.00337	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TP53—melanoma	0.00011	0.00337	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000108	0.00332	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—KRAS—melanoma	0.000102	0.00312	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.0001	0.00308	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL6—melanoma	0.0001	0.00308	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—TNF—melanoma	9.88e-05	0.00303	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—melanoma	9.88e-05	0.00303	CbGpPWpGaD
Cefdinir—Cefazolin—ALB—melanoma	9.15e-05	0.0138	CrCbGaD
Cefdinir—Ceftriaxone—ALB—melanoma	8.67e-05	0.0131	CrCbGaD
Cefdinir—MPO—C-MYB transcription factor network—HRAS—melanoma	8.65e-05	0.00266	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IL6—melanoma	7.98e-05	0.00245	CbGpPWpGaD
Cefdinir—Cefalotin—ALB—melanoma	7.6e-05	0.0114	CrCbGaD
Cefdinir—Cephalexin—ALB—melanoma	6.91e-05	0.0104	CrCbGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	5.5e-05	0.00169	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	5.16e-05	0.00158	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	5.11e-05	0.00157	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC5A5—melanoma	5.02e-05	0.00154	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	4.79e-05	0.00147	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—ALB—melanoma	4.71e-05	0.00145	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	4.19e-05	0.00129	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	3.89e-05	0.00119	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCB1—melanoma	3.83e-05	0.00118	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	2.62e-05	0.000805	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	2.44e-05	0.000747	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ALB—melanoma	2.39e-05	0.000735	CbGpPWpGaD
